CN1879806A - A medicine for treating herpes zoster - Google Patents

A medicine for treating herpes zoster Download PDF

Info

Publication number
CN1879806A
CN1879806A CNA2006100403582A CN200610040358A CN1879806A CN 1879806 A CN1879806 A CN 1879806A CN A2006100403582 A CNA2006100403582 A CN A2006100403582A CN 200610040358 A CN200610040358 A CN 200610040358A CN 1879806 A CN1879806 A CN 1879806A
Authority
CN
China
Prior art keywords
grams
herpes zoster
hours
medicine
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006100403582A
Other languages
Chinese (zh)
Other versions
CN100556438C (en
Inventor
张江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100403582A priority Critical patent/CN100556438C/en
Publication of CN1879806A publication Critical patent/CN1879806A/en
Application granted granted Critical
Publication of CN100556438C publication Critical patent/CN100556438C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is a medicament for treating liver cirrhosis comprising the following constituents (by weight ratio): earthworm 17%, herb of Chinese fevervine 1%, corktree bark 1%, paris rhizome 1%, interwined dragon ginseng 1%, laver 1-4%, eucommia bark 4%, cane sugar 17%, and boiled water 58%.

Description

A kind of medicine for the treatment of herpes zoster
Affiliated technical field
The present invention relates to a kind of medicine, especially a kind of medicine for the treatment of herpes zoster.
Background technology
At present, a kind of herpes zoster that is caused by virus is the acute herpetic dermatosis, and its diseased region mainly is distributed in the district that moves towards of somatic nerves, one-sided is at most with the waist, secondly is extremity, after its disease takes place, easily merge and cause lymphadenitis, even after herpes was cured, its neuralgia still existed, that have even increase the weight of, at present to this sick general treatement, many curative effects are very slow, mostly be just to take effect in 2~3 weeks, patient's misery, and cost is high, does not also have highly effective solution at present.
Summary of the invention
In order to solve effective treatment problem, the invention provides a kind of medicine for the treatment of herpes zoster, the banded herpes of this Drug therapy to herpes zoster, can fully recover in 48 hours to 72 hours, curative effect is very fast, and cost seldom, and no sequel can effectively reduce patient's misery.
Proportioning and Therapeutic Method that the present invention is concrete are:
Pheretima: 17%, fevervine: 1%, Cortex Phellodendri: 1%, Rhizoma Paridis: 1%, Radix seu Herba Spiranthis Lanceae: 1%, osmund: 4%, Herba Asari Forbesii: 4%, the precision preparation of above Chinese medicine all is 0.5%; Its Therapeutic Method is: these medicines are ground to form 50~150 purpose powder, and the sucrose with 17%, 58% boiled water, mix homogeneously soaked after 24 hours, and external is embrocated, and 24 hours to 72 hours, can fully recover, and not stay sequela.
The pharmacology of this medicine is:
This side's heat clearing away, relieving convulsion, pathogenic fire purging, YIN nourishing, detoxifcation, dredge the meridian passage, diuretic swell; Cortex Phellodendri wherein: the quench detoxifcation, detumescence, tissue regeneration promoting meat removing the necrotic tissue is turbid; Flea body, Radix seu Herba Spiranthis Lanceae, fevervine: let out fire, circulation of qi promoting stagnates, and dispersing swelling and dissipating binds is separated fire-toxin; Pheretima: dredge the meridian passage, diuretic swell, invigorate blood circulation, repercussive stagnates, and change the stagnation pain, osmund, Herba Asari Forbesii: detumescence poison, blood stasis dispelling stagnate, and the intercostal nerves that repairing and treating is impaired is treated arthralgia pain; Sucrose: antiinflammatory, anticorrosion, promote the production of body fluid.
Its beneficial effect is: the banded herpes of this Drug therapy, can fully recover in 48 hours to 72 hours, and curative effect is very fast, and cost is few, and does not have any sequela, can effectively reduce patient's misery.
Specific embodiment
The concrete counterweight ratio of embodiment is: Pheretima: 60 grams, fevervine: 3 grams, Cortex Phellodendri: 3 grams, Rhizoma Paridis: 3 grams, Radix seu Herba Spiranthis Lanceae: 3 grams, osmund: 15 grams, Herba Asari Forbesii: 15 grams; Grind to form 100 order fine powders, with 60 gram sucrose, 200 gram boiled water mix homogeneously soaked 24 hours, and external is embrocated and got final product.

Claims (2)

1 one kinds of medicines for the treatment of herpes zoster, the concrete counterweight of its feature when Therapeutic Method is: Pheretima: 17%, fevervine: 1%, Cortex Phellodendri: 1%, Rhizoma Paridis: 1%, Radix seu Herba Spiranthis Lanceae: 1%, osmund: 4%, Herba Asari Forbesii: 4%, these Chinese medicines are ground to form 50~150 order powder, add 17% sucrose, 58% boiled water, mix homogeneously soaks after 24 hours external and embrocates.
2 a kind of medicines for the treatment of herpes zoster according to claim 1, the concrete important proportioning of its feature is: Pheretima: 60 grams, fevervine: 3 grams, Cortex Phellodendri: 3 grams, Rhizoma Paridis: 3 grams, Radix seu Herba Spiranthis Lanceae: 3 grams, osmund: 15 grams, Herba Asari Forbesii: 15 grams; Above medicine is ground to form 100 order fine powders, and with 60 gram sucrose, 200 gram boiled water mix homogeneously soaked 24 hours, and external is embrocated.
CNB2006100403582A 2006-05-18 2006-05-18 A kind of medicine for external application for the treatment of herpes zoster Expired - Fee Related CN100556438C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100403582A CN100556438C (en) 2006-05-18 2006-05-18 A kind of medicine for external application for the treatment of herpes zoster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100403582A CN100556438C (en) 2006-05-18 2006-05-18 A kind of medicine for external application for the treatment of herpes zoster

Publications (2)

Publication Number Publication Date
CN1879806A true CN1879806A (en) 2006-12-20
CN100556438C CN100556438C (en) 2009-11-04

Family

ID=37518307

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100403582A Expired - Fee Related CN100556438C (en) 2006-05-18 2006-05-18 A kind of medicine for external application for the treatment of herpes zoster

Country Status (1)

Country Link
CN (1) CN100556438C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105560639A (en) * 2015-09-08 2016-05-11 张丽娜 Traditional Chinese medicine for treating herpes zoster erythema multiforme exudativum

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105560639A (en) * 2015-09-08 2016-05-11 张丽娜 Traditional Chinese medicine for treating herpes zoster erythema multiforme exudativum

Also Published As

Publication number Publication date
CN100556438C (en) 2009-11-04

Similar Documents

Publication Publication Date Title
CN101062357A (en) Medicine for treating peptic ulcer and chronic gastritis
CN111840383A (en) Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof
CN1325110C (en) Medicated wine for treating traumatic injury
CN102895610A (en) Medicine for treating edema
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN101897753B (en) Traditional Chinese medicine for treating coronary disease and preparation method thereof
CN1879806A (en) A medicine for treating herpes zoster
CN1051933C (en) Traditional Chinese medicine composition for treating refractory headache
CN101716296A (en) Traditional Chinese medicine pill for treating psoriasis
CN112717096A (en) Chinese herbal medicine foot bath powder capable of reducing uric acid and dissipating wind and tonifying kidney
CN1176690C (en) Medicine for treating chronic nephritis
CN1907345A (en) Chinese traditional medicine composition for treating cerebral apoplexy
CN1903244A (en) Traditional Chinese medicine composition for treating sexual disorders
CN104288597A (en) Traditional Chinese medicine composition for treating herpes zoster
CN1475243A (en) External medicine for treating leucoderma
CN101890069A (en) Medicament for preventing and treating gout and preparation process thereof
CN1172701C (en) Medicine for curing herpes zoster
CN115804805B (en) Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag
CN1277577C (en) Chinese traditional medicine for treating cerebral thrombosis, preparation method and application
CN1054986C (en) Chinese medicine pill for treating rheumatoid disease
CN1305505C (en) Medicament for treating prostatauxe inflammation
CN1308952A (en) Chinese medicine for treating trigeminal neuraligia and its preparing process
CN108066738B (en) Ointment for treating gouty arthritis and preparation method thereof
CN1698801A (en) Capsule for treating hemiplegia and rheumatism
CN1225269C (en) Medicine for treating prospoalgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: Jiangsu province Fengxian County Fengming District 10 Building 2 unit 401 room

Patentee after: Zhang Jiang

Address before: Worker's Hospital of Chang Shuang Lou coal mine, Peixian, Jiangsu

Patentee before: Zhang Jiang

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091104

Termination date: 20100518